Stock HI-TECH PHARMACAL CO.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News Hi-Tech Pharmacal Co.

Equities

US42840B1017

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Hi Tech Pharmacal : Akorn Completes Acquisition of Hi-Tech Pharmacal
BU
Hi Tech Pharmacal : Akorn Receives FTC Clearance for Hi-Tech Pharmacal Acquisition
BU
Hi-Tech Pharmacal Co. : Hi-Tech Pharmacal Reports Sales of $59.9 Million for the Third Quarter Ended January 31, 2014
BU
Hi-Tech Pharmacal Co. : Hi-Tech Pharmacal Receives Final Approval for Bromfenac Ophthalmic Solution, 0.09% (Once-A-Day)
BU
Hi-Tech Pharmacal Co. : Hi-Tech Pharmacal Announces Settlement Regarding Texas Pricing Investigation
BU
Hi-Tech Pharmacal Co. : Hi-Tech Pharmacal Reports Sales of $58.6 million for the Second Quarter Ended October 31, 2013
BU
Hi-Tech Pharmacal Co. : Hi-Tech Pharmacal to Release First Quarter Earnings and Hold Conference Call on September 9, 2013
BU
Hi-Tech Pharmacal Co. : HI-TECH PHARMACAL INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Hi-Tech Pharmacal Co., Inc. Following Announcement of Proposed Sale of Company to Akorn, Inc.
BU
Hi-Tech Pharmacal Co. : Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Hi-Tech Pharmacal Co., Inc. Shareholders
BU
Hi-Tech Pharmacal Co. : Ryan & Maniskas, LLP Announces Investigation of Hi-Tech Pharmacal Co., Inc.
PR
Hi-Tech Pharmacal Co. : Akorn to Acquire Hi-Tech Pharmacal for $640 Million
BU
Hi-Tech Pharmacal Co. : Health Care Products Division of Hi-Tech Pharmacal Receives FDA Warning Letter Related to Labeling Statements on Certain OTC Products
BU
Hi-Tech Pharmacal Co. : Hi-Tech Pharmacal to Release Fourth Quarter Earnings and Hold Conference Call on July 9, 2013
BU
Hi-Tech Pharmacal Co. : Hi-Tech Pharmacal to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
BU
Hi-Tech Pharmacal Co. : ECR Pharmaceuticals Announces Re-launch of Zolpimist® and DexPak®, Divestiture of Hylase® and Orbivan® Brands, and Dr. Cameron Durrant Named President and CEO
BU
Hi-Tech Pharmacal Co. : Hi-Tech Pharmacal to Present at the Needham 12th Annual Healthcare Conference
BU
Hi-Tech Pharmacal Co. : Hi-Tech Pharmacal Reports Sales of $64.3 Million and EPS of $0.43 for the Third Quarter Ended January 31, 2013
BU
Hi-Tech Pharmacal Co. : Hi-Tech Pharmacal to Release Third Quarter Earnings and Hold Conference Call on March 7, 2013
BU
Hi-Tech Pharmacal Co. : Hi-Tech Pharmacal to Present at the 2013 RBC Capital Markets' Healthcare Conference
BU
Hi-Tech Pharmacal Co. : Hi-Tech Pharmacal to Present at the Oppenheimer 23rd Annual Healthcare Conference
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. Stock
  4. News Hi-Tech Pharmacal Co.